TrialJournal of nephrology2015

Sevelamer is cost effective versus calcium carbonate for the first-line treatment of hyperphosphatemia in new patients to hemodialysis: a patient-level economic evaluation of the INDEPENDENT-HD study.

Matteo Ruggeri et al.PubMed ↗Publisher ↗

No numbers read from the abstract.